~~<i id='41898BEF99'><strike id='41898BEF99'><tt id='41898BEF99'><pre id='41898BEF99'></pre></tt></strike></i>~~

Home» explore» entertainment

entertainment

author：comprehensive 2025-10-02 01:46:00 Page View：19

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources
Next article： Activists slam private health insurers over coverage restrictions

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

Stoke drug shows lower activity against childhood epilepsy

AdobeStokeTherapeuticsisstillseekinganeffectivedoseforanexperimentaldrugtotreatasevereformofchildhoo

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

An outrageous hospital charge: I paid $710 for an hour of babysitting

FREDDUFOUR/AFP/GettyImagesAfewhoursaftermydaughter,Penelope,wasborn,anursecameintothehospitalroomand